Medicare Enrolled
Dr. Megan Mackenzie, D.O.
Neurology · Centerville, OH
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Mackenzie from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Mackenzie?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Mackenzie
Dr. Megan Mackenzie is a neurology specialist in Centerville, OH, with 14 years of NPI registration. Based on federal Medicare data, Dr. Mackenzie performed 17,932 Medicare services across 494 unique beneficiaries.
Between the years covered by Open Payments, Dr. Mackenzie received a total of $64,285 from 76 pharmaceutical and/or device companies across 1313 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Mackenzie is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 14 years in practice
▲ Top 3% volume in OH
$64,285 industry payments
Medicare Practice Summary
Medicare Utilization ↗17,932
Medicare services
Top 3% in OH for neurology
494
Unique beneficiaries
$9
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~1,281 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Botox injection, per unit An injection of onabotulinumtoxinA, a medication used to temporarily relax muscles or reduce gland activity. The dose is measured in units, with this code representing a single unit administered. |
17,329 | $5 | $8 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
140 | $135 | $528 |
| Chemical nerve block for neck muscles Injection of a chemical agent to paralyze specific muscles on the side of the neck, excluding the voice box. |
85 | $137 | $451 |
| Chemical nerve block for facial paralysis Injection of a chemical agent to paralyze specific nerves or muscles on the side of the face. |
64 | $74 | $654 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
64 | $94 | $183 |
| Awake and drowsy EEG A test that records electrical activity in the brain while the patient is awake and drowsy. |
37 | $275 | $650 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
33 | $83 | $206 |
| Injection of anesthetic agent and/or steroid into other nerve or branch | 27 | $82 | $326 |
| New patient office visit, complex (60-74 min) | 27 | $166 | $372 |
| Methylprednisolone acetate injection, 20 mg A 20 mg injection of methylprednisolone acetate, a corticosteroid medication. This code specifies the drug and dosage administered. |
27 | $4 | $15 |
| Injection of anesthetic or steroid into upper neck and back of head nerve An injection of an anesthetic agent and/or steroid into a nerve located in the upper neck and back of the head. |
25 | $31 | $203 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
18 | $62 | $128 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
16 | $103 | $360 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
14 | $129 | $258 |
| Digital analysis of brain wave activity (EEG) This procedure involves the digital analysis of brain wave activity recorded via an electroencephalogram (EEG). It focuses on the technical interpretation of the digital data rather than the initial recording or supervision. |
13 | $209 | $784 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
13 | $101 | $319 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$64,285
Total received (2018-2024)
Avg $9,184/year across 7 years
Top 12% in OH for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
76
Companies
1,313
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$46,684 (72.6%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$17,601 (27.4%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$3,091
2023
$2,322
2022
$10,711
2021
$20,713
2020
$12,722
2019
$11,799
2018
$2,926
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$690
MDD US Operations, LLC
$579
EMD Serono, Inc.
$274
PFIZER INC.
$219
Novartis Pharmaceuticals Corporation
$168
UCB, Inc.
$142
Lilly USA, LLC
$135
Neurocrine Biosciences, Inc.
$135
Teva Pharmaceuticals USA, Inc.
$132
ACADIA Pharmaceuticals Inc
$90
Genentech USA, Inc.
$66
Lundbeck LLC
$59
SK Life Science, Inc.
$54
ARGENX US, INC.
$50
Eisai Inc.
$27
Otsuka America Pharmaceutical, Inc.
$26
Biogen, Inc.
$25
JAZZ PHARMACEUTICALS INC.
$22
GE HEALTHCARE
$22
Amneal Pharmaceuticals LLC
$22
Acorda Therapeutics, Inc
$21
Alexion Pharmaceuticals, Inc.
$21
Takeda Pharmaceuticals U.S.A., Inc.
$21
Philips North America LLC
$20
BANNER LIFE SCIENCES, LLC
$20
Merz Pharmaceuticals, LLC
$19
Sumitomo Pharma America, Inc.
$16
Ipsen Biopharmaceuticals, Inc
$14
Top 3 companies account for 49.9% of 2024 payments
All-time payments by company (2018-2024) ›
Lilly USA, LLC
$32,599
Biohaven Pharmaceuticals, Inc.
$8,942
Biohaven Pharmaceutical Holding Company Ltd.
$4,908
Novartis Pharmaceuticals Corporation
$1,864
ABBVIE INC.
$1,567
Amgen Inc.
$1,480
Teva Pharmaceuticals USA, Inc.
$1,146
Biogen, Inc.
$885
EMD Serono, Inc.
$853
MDD US Operations, LLC
$817
Supernus Pharmaceuticals, Inc.
$707
Allergan Inc.
$659
UCB, Inc.
$535
GENZYME CORPORATION
$526
PFIZER INC.
$523
Allergan, Inc.
$479
ACADIA Pharmaceuticals Inc
$421
Alexion Pharmaceuticals, Inc.
$401
Lundbeck LLC
$336
SK Life Science, Inc.
$309
AbbVie Inc.
$305
Genentech USA, Inc.
$287
Neurocrine Biosciences, Inc.
$266
Acorda Therapeutics, Inc
$231
Sunovion Pharmaceuticals Inc.
$218
Avanir Pharmaceuticals, Inc.
$204
Amneal Pharmaceuticals LLC
$190
Janssen Pharmaceuticals, Inc
$168
CSL Behring
$158
Adamas Pharmaceuticals, Inc.
$144
Horizon Therapeutics plc
$143
Greenwich Biosciences, Inc.
$137
Abbott Laboratories
$129
Impax Laboratories, Inc.
$106
Ipsen Biopharmaceuticals, Inc
$100
Jazz Pharmaceuticals Inc.
$80
Medtronic USA, Inc.
$78
ARGENX US, INC.
$72
Merz North America, Inc.
$71
AstraZeneca Pharmaceuticals LP
$64
Neurelis, Inc.
$64
Merz Pharmaceuticals, LLC
$64
Sumitomo Pharma America, Inc.
$57
Zyla Life Sciences
$56
Amylyx Pharmaceuticals, Inc.
$53
E.R. Squibb & Sons, L.L.C.
$47
Egalet US Inc
$43
TG THERAPEUTICS, INC.
$42
JAZZ PHARMACEUTICALS INC.
$42
GE HEALTHCARE
$39
Eisai Inc.
$39
Mallinckrodt LLC
$39
ARBOR PHARMACEUTICALS, INC.
$37
AbbVie, Inc.
$33
HARMONY BIOSCIENCES LLC
$32
US WorldMeds, LLC
$32
Zyla Life Sciences, Inc.
$30
Alnylam Pharmaceuticals Inc.
$28
Kyowa Kirin, Inc.
$27
Grifols USA, LLC
$27
Otsuka America Pharmaceutical, Inc.
$26
Catalyst Pharmaceuticals, Inc.
$25
Averitas Pharma Inc.
$25
Assertio Therapeutics, Inc.
$25
EISAI INC.
$24
InSightec,Inc
$24
Vertical Pharmaceuticals, LLC
$24
Promius Pharma LLC
$22
Scilex Pharmaceuticals Inc.
$21
Bayer HealthCare Pharmaceuticals Inc.
$21
Takeda Pharmaceuticals U.S.A., Inc.
$21
Philips North America LLC
$20
BANNER LIFE SCIENCES, LLC
$20
Mylan Pharmaceuticals Inc.
$16
Alfasigma USA, Inc.
$16
ASSERTIO THERAPEUTICS, INC.
$15
Top 3 companies account for 72.3% of all-time payments
Associated products mentioned in payments ›
(CK4) MCOT · ACTHAR · ADUHELM · AIMOVIG · AJOVY · AMPYRA · AMYVID · APOKYN · APTIOM · AUBAGIO · AUSTEDO · AVONEX · Aimovig · Austedo XR · BAFIERTAM · BOTOX · BOTOX - NEUROLOGY · BOTOX THERAPEUTIC · BRILINTA · BRIUMVI · Betaseron · Briviact · COMIRNATY · Cambia · DUOPA · DYSPORT · Duopa · Dysport · EFFIENT · EMGALITY · EPIDIOLEX · Enspryng · Epidiolex · Exablate · FYCOMPA · Fycompa · GILENYA · GOCOVRI · Gamunex-C · Glatiramer Acetate · Gocovri · Gralise · HYQVIA · Hizentra · Horizant · INBRIJA · INFINITY · INGREZZA · INTELLIS · KESIMPTA · KYNMOBI · LEMTRADA · LYRICA · LYVISPAH · Leqembi · MAVENCLAD · MAYZENT · MYOBLOC · Mavenclad · NAMZARIC · NORTHERA · NOURIANZ · NUEDEXTA · NUPLAZID · NURTEC ODT · Nayzilam · Nuedexta · OCREVUS · OCTAGAM IMMUNE GLOBULIN (HUMAN) · ONFI · ONPATTRO · OSMOLEX ER · OXTELLAR XR · Ocrevus · Ongentys · PANZYGA · Ponvory · QULIPTA · QUTENZA · RELEXXII · RELYVRIO · REXULTI · RYTARY · Rebif · Rystiggo · SOLIRIS · SPINRAZA · SPRIX · Soliris · TECFIDERA · TROKENDI XR · TYSABRI · UBRELVY · ULTOMIRIS · UPLIZNA · VALTOCO · VRAYLAR · VUMERITY · VYALEV · VYEPTI · VYVGART · VYVGART HYTRULO · Vimpat · Wakix · XADAGO · XARELTO · XEOMIN · XYREM · XYWAV · Xeomin · Xyrem · ZEMBRACE SYMTOUCH · ZEPOSIA · ZTLido · Zilbrysq
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (73%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in neurology and does not inherently indicate bias, but patients may wish to be aware.
Geographic Context
Neurologists within 10 mi
61
Per 100K population
11.4
County median income
$64,403
Nearest hospital
KETTERING HEALTH MAIN CAMPUS
2.6 mi
2.6 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Mackenzie is a mixed practice specialist, with above-average Medicare volume (top 3% in OH), with speaking/promotional industry engagement in the top 12% of OH peers.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Mackenzie experienced with botox injection, per unit?
Based on Medicare claims data, Dr. Mackenzie performed 17,329 botox injection, per unit services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Mackenzie receive payments from pharmaceutical companies?
Yes. Dr. Mackenzie received a total of $64,285 from 76 companies across 1,313 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Mackenzie's costs compare to other neurologists in Centerville?
Dr. Mackenzie's average Medicare payment per service is $9. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Mackenzie) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Neurology
Common procedures, typical costs, and what industry payments mean in neurology.
Same specialty & city
Neurologists in Centerville
Browse neurologists in Centerville ranked by procedure volume and transparency data.
Highest volume
Top Neurologists in OH
Neurologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Neurologists in OH
Which OH neurologists receive the most from drug and device companies.
By company
Lilly USA, LLC Payments to Doctors
See all physicians who received payments from Lilly USA, LLC.
By company
Biohaven Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Biohaven Pharmaceuticals, Inc.
By company
Biohaven Pharmaceutical Holding Company Ltd. Payments to Doctors
See all physicians who received payments from Biohaven Pharmaceutical Holding Company Ltd.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology